What You Should Know: - Carbon Health, a technology-enabled healthcare provider, announced the acquisition of Steady Health, a fully integrated diabetes platform that uses data from continuous glucose monitoring (CGM) devices to provide personalized medical care from top endocrinologists. Financial details of the acquisition were not disclosed. - The Steady Health acquisition accelerates Carbon Health’s rollout of an innovative new primary care model, which integrates Carbon Health’s
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Glooko Integrates with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets
What We Should Know: - Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions. - The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen™ and
Read More
Medtronic Launches Initiatives to Address Health Equity for People of Color Living with Diabetes
What You Should Know: - Medtronic announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities. New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities Details of each partnership, as well as additional
Read More
Glooko Raises $30M to Expand Digital Diabetes Management Platform
What You Should Know: - Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. - Glooko plans to use these proceeds from this funding to accelerate organic growth and
Read More
Data-Driven Future: Impact of Machine Learning on Diabetes Management
“Information technology and business are becoming inextricably interwoven. I don't think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare. The ability to collect, analyze, and use data is becoming ubiquitous with many of healthcare’s most exciting advancements. Whether it’s Google’s DeepMind using artificial intelligence (AI) to help
Read More
Verily’s Onduo Virtual Care Solution Expands to Multi-Condition Platform
What You Should Know: - Verily's Onduo, known for its tech-based solution for virtual diabetes management, is launching a new multi-condition platform that matches the right care to the right consumer at the right time. The expanded virtual care platform is designed to support patients managing type 2 diabetes and hypertension, with plans for further expansion into mental and behavioral health.- In addition, Onduo has introduced multi-language support to make the virtual
Read More
Teladoc Health, Dexcom Offers CGM-Powered Insights to People with Type 2 Diabetes
What You Should Know: - Teladoc Health and Dexcom announced an expanded
partnership on a new offering measures the impact of continuous glucose
monitoring and real-time health recommendations for people with Type 2 diabetes
at no cost. Teladoc Health, Inc., the first and only comprehensive virtual care system, and DexCom, Inc., the leader in real-time continuous glucose monitoring (CGM), today announced that joint Livongo for Diabetes and Dexcom members will now
Read More
4 Predictions for Diabetes Management and Technology in 2021
The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of technology to address dire patient needs. Health systems, physicians, and frontline staff pulled together in remarkable fashion to implement these emerging technologies that enhance the ways patients
Read More
Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population
What You Should Know: - Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. - Vida’s diabetes management program
achieves lasting results for participants. Because chronic conditions like diabetes,
obesity, and hypertension often occur simultaneously, Vida’s unique program was
built from the ground up to treat multiple conditions at the same time. - The new partnership, which will
Read More
Digital Diabetes Market to Reach $1.5B by 2024, Research Finds
What You Should Know: - The digital diabetes market is on track to reach $1.5
billion dollars by 2024, according to a new report by Research2Guidance. - The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million. - Digital diabetes solutions have disrupted the
Read More
